Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride.

Baker, B R

Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride. [electronic resource] - Journal of medicinal chemistry Mar 1969 - 224-7 p. digital

Publication Type: Journal Article

0022-2623

10.1021/jm00302a007 doi


Animals
Binding Sites
Fluorides--chemical synthesis
Folic Acid Antagonists
In Vitro Techniques
Leukemia L1210--enzymology
Liver--enzymology
Mice
Pyrimidines--chemical synthesis
Sulfones--chemical synthesis